AcousticaBio improves clinical care by reformulating intravenously-delivered biologic products for subcutaneous injection. Patients can then administer their life saving drugs with reduced pain and discomfort and without long, costly hospital visits. AcousticaBio enables IV to SC reformulation through our proprietary technology: acoustophoretic printing. Our technology is uniquely suited to creating the complex microparticles necessary for subcutaneous formulations.
Connect with AcousticaBio
